Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 71,434 | 60,698 | 47,485 | 49,581 | 43,112 |
| Operating Income | -71,434 | -60,698 | -47,485 | -49,581 | -43,112 |
| Interest Expense | 3,198 | 2,037 | 18 | 0 | 0 |
| Other Income | 4,053 | 6,779 | 7,097 | 3,226 | 7,090 |
| Pre-tax Income | -70,579 | -55,956 | -40,406 | -46,355 | -36,022 |
| Income Tax | 115 | 95 | 153 | 41 | 92 |
| Net Income Continuous | -70,694 | -56,051 | -40,559 | -46,396 | -36,114 |
| Minority Interests | -965 | -831 | -615 | -791 | -724 |
| Net Income | $-69,729 | $-55,220 | $-39,944 | $-45,606 | $-35,390 |
| EPS Basic Total Ops | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 |
| EPS Basic Continuous Ops | -1.12 | -0.89 | -0.64 | -0.74 | -0.57 |
| EPS Diluted Total Ops | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 |
| EPS Diluted Continuous Ops | -1.12 | -0.89 | -0.64 | -0.74 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 |
| EBITDA(a) | $-70,689 | $-59,956 | $-47,107 | $-49,217 | $-42,761 |